KR920701445A - 쉬스토조마 맨소니의 글루타티온 에스-전이효소 sm26 - Google Patents
쉬스토조마 맨소니의 글루타티온 에스-전이효소 sm26Info
- Publication number
- KR920701445A KR920701445A KR1019910701272A KR910701272A KR920701445A KR 920701445 A KR920701445 A KR 920701445A KR 1019910701272 A KR1019910701272 A KR 1019910701272A KR 910701272 A KR910701272 A KR 910701272A KR 920701445 A KR920701445 A KR 920701445A
- Authority
- KR
- South Korea
- Prior art keywords
- protein
- amino acid
- sequence
- acid sequence
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000005720 Glutathione transferase Human genes 0.000 title claims 2
- 108010070675 Glutathione transferase Proteins 0.000 title claims 2
- 102000004169 proteins and genes Human genes 0.000 claims description 19
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 150000001413 amino acids Chemical group 0.000 claims description 9
- 239000012634 fragment Substances 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims 18
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 4
- 108020004414 DNA Proteins 0.000 claims 3
- 235000001014 amino acid Nutrition 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 claims 1
- 108020004635 Complementary DNA Proteins 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 206010038687 Respiratory distress Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000010804 cDNA synthesis Methods 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 230000000147 hypnotic effect Effects 0.000 claims 1
- 239000006166 lysate Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000001243 protein synthesis Methods 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000014616 translation Effects 0.000 claims 1
- 229920000936 Agarose Polymers 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
- C12N9/1088—Glutathione transferase (2.5.1.18)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR90/01403 | 1990-02-07 | ||
| FR9001403A FR2657883A1 (enExample) | 1990-02-07 | 1990-02-07 | |
| PCT/FR1991/000091 WO1991012327A1 (fr) | 1990-02-07 | 1991-02-06 | Glutathion-s-transferase sm26 de s. mansoni |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR920701445A true KR920701445A (ko) | 1992-08-11 |
Family
ID=9393459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019910701272A Withdrawn KR920701445A (ko) | 1990-02-07 | 1991-02-06 | 쉬스토조마 맨소니의 글루타티온 에스-전이효소 sm26 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0466912A1 (enExample) |
| JP (1) | JPH04505402A (enExample) |
| KR (1) | KR920701445A (enExample) |
| AU (1) | AU645786B2 (enExample) |
| CA (1) | CA2051695A1 (enExample) |
| FR (1) | FR2657883A1 (enExample) |
| WO (1) | WO1991012327A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2745695A (en) * | 1994-06-22 | 1996-01-15 | Imperial College Of Science, Technology And Medicine | Schistosoma protein and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU613583B2 (en) * | 1986-08-22 | 1991-08-08 | Transgene S.A. | Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity |
| NZ224663A (en) * | 1987-05-28 | 1990-11-27 | Amrad Corp Ltd | Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors |
| NZ232327A (en) * | 1989-01-31 | 1993-02-25 | Daratech Pty Ltd | Vaccine for preventative treatment of liver fluke infection in ruminants comprising as an antigen glutathione-s-transferase (gst) of f. hepatica |
-
1990
- 1990-02-07 FR FR9001403A patent/FR2657883A1/fr active Pending
-
1991
- 1991-02-06 AU AU73333/91A patent/AU645786B2/en not_active Expired - Fee Related
- 1991-02-06 WO PCT/FR1991/000091 patent/WO1991012327A1/fr not_active Ceased
- 1991-02-06 KR KR1019910701272A patent/KR920701445A/ko not_active Withdrawn
- 1991-02-06 EP EP91904781A patent/EP0466912A1/fr not_active Withdrawn
- 1991-02-06 CA CA002051695A patent/CA2051695A1/fr not_active Abandoned
- 1991-02-06 JP JP3505493A patent/JPH04505402A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU645786B2 (en) | 1994-01-27 |
| EP0466912A1 (fr) | 1992-01-22 |
| WO1991012327A1 (fr) | 1991-08-22 |
| JPH04505402A (ja) | 1992-09-24 |
| AU7333391A (en) | 1991-09-03 |
| FR2657883A1 (enExample) | 1991-08-09 |
| CA2051695A1 (fr) | 1991-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gustafson et al. | Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the CyanobacteriumNostoc ellipsosporum | |
| DK714788A (da) | Polypeptider og derivater deraf samt deres anvendelse i pharmaceutiske og diagnostiske praeparater | |
| DK305885A (da) | Tumornecrosefaktor og derivater og mutantformer deraf, frem. til frems. deraf, frem. til isolering deraf fra en blanding med andre proteiner,praeparater deraf, dna som koder derfor, dna'en inkorporeret i en replicerbar vektor og celle transformeret dermed | |
| RU95115239A (ru) | Аналог эритропоэтина | |
| KR960700340A (ko) | 안정한 살균/투과성-증가 단백질 생성물 및 그를 포함하는 제약학적 조성물(stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same) | |
| DE69333802D1 (de) | Äusseres membranprotein von haemophilus | |
| RU93046317A (ru) | Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции | |
| ATE80180T1 (de) | Herstellung eines igg-bindenden proteins zum erleichtern der weiterverarbeitung mittels ''protein-engineering''. | |
| DK79190A (da) | Praktisk taget rent polypeptid og dets anvendelse; rekombinantvirus, rekombinantvirus, rekomninant-dna-vektor og encellet organisme til dets fremstilling | |
| BR9712518A (pt) | Polipeptìdeo, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processo para detectar tuberculose em um paciente, e, kit diagnóstico | |
| KR880007734A (ko) | 폴리펩타이드 유도체 | |
| NO914541L (no) | Fremgangsmaate ved fremstilling av tumor-nekrose-faktor-muteiner | |
| DE3066654D1 (en) | Acyl peptides and pharmaceutical preparations thereof, as well as their manufacture and use | |
| BR9408006A (pt) | Molécula de ácido nucléico isolada e purificada vetor e vetor de express o adaptados para transformaçao de hospedeiro hospedeiro transformado proteina receptora "transferrin" recombinante ou fragmento ou análogo da mesma proteina Tbpl purificada e isolada proteina Tbp2 purificada e isolada peptídeo composiç o imunogênica vetor ativo para fornecimento de proteina receptora "transferrin" vetor de plasmideo linhagem de haemophilus processo para produzir proteina Tbp2 ou Tbpl purificada e isolada | |
| KR880009125A (ko) | 재조합 숙주에 의해 제조되는 췌장분비 트립신 억제제 및 그의 변이체, 그의 방법, 표현벡터 및 재조합 숙주 및 그의 제약상 용도 | |
| DK100487A (da) | Hidtil ukendte carbonsyrederivater, fremgangsmaade til deres fremstilling, deres anvendelse samt laegemidler indeholdende disse forbindelser | |
| BR9803960A (pt) | Gene de desidrogenase de d-sorbitol. | |
| BR112022011975A2 (pt) | Polipeptídeo de interferon-¿2 modificado, polipeptídeo gmop-interferon-¿2 modificado, ácido nucleico, plasmídeo, vetor, linha de célula, método para purificação do polipeptídeo de interferon-¿2 modificado, composição farmacêutica, método para uso de um ou mais dos polipeptídeos de interferon-¿2 modificados e método para tratar uma condição médica em um indivíduo | |
| Kramps et al. | The polypeptide chains of α-crystallin from old human eye lenses | |
| IE871871L (en) | Cloning and expression of acidic fibroblast growth factor | |
| Fujimoto et al. | Intraspecies composition difference in collagen from cuticle and body of Ascaris and Lumbricus | |
| Georges et al. | Chemical modification of charged amino acid moieties alters the electrophoretic mobilities of neurofilament subunits on SDS/polyacrylamide gels | |
| AMMER et al. | The major protamine from stallion sperm. Isolation and amino-acid sequence | |
| KR920701445A (ko) | 쉬스토조마 맨소니의 글루타티온 에스-전이효소 sm26 | |
| KR880009127A (ko) | 용성 성숙 hIL-β 및 변경된 생물학적 활성을 갖는 유도체를 이 콜라이에서 고도로 발현시키는 플라즈미드 및 그 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19911007 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |